Category index
Appearance
This page is a hierarchical index of all pharmacological categories used throughout Pharmacopedia. Click any category name to browse its members. For descriptions of each class, see Classes.
Antidepressants (34)
- Selective Serotonin Reuptake Inhibitors (SSRIs) (6)
- Serotonin–Norepinephrine Reuptake Inhibitors (SNRIs) (4)
- Norepinephrine–Dopamine Reuptake Inhibitors (NDRIs) (0)
- Norepinephrine Reuptake Inhibitors (NRIs) (0)
- Tricyclic Antidepressants (TCAs) (10)
- Monoamine Oxidase Inhibitors (MAOIs) (4)
- Irreversible non-selective MAOIs (0)
- Reversible MAO-A inhibitors (RIMAs) (0)
- Selective MAO-B inhibitors (0)
- Noradrenergic and Specific Serotonergic Antidepressants (NaSSAs) (0)
- Serotonin Antagonist and Reuptake Inhibitors (SARIs) (0)
- Melatonin Agonist / Serotonin Antagonist (0)
- Multimodal Serotonergic Agents (0)
- First-Generation Antipsychotics (FGAs / Typicals) (11)
- Phenothiazines (0)
- Butyrophenones (0)
- Thioxanthenes (0)
- Dibenzoxazepines (0)
- Dihydroindolones (0)
- Diphenylbutylpiperidines (0)
- Second-Generation Antipsychotics (SGAs / Atypicals) (13)
- Third-Generation Antipsychotics (0)
Mood Stabilizers (4)
- Anxiolytics (20)
- Benzodiazepines (28)
- Thienodiazepines (0)
- Z-Drugs (Non-Benzodiazepine Hypnotics) (4)
- Orexin Receptor Antagonists (2)
- Azapirones (0)
- Barbiturates (6)
- Amphetamines (12)
- Methylphenidates (Phenidates) (8)
- Eugeroics (Wakefulness-Promoting Agents) (4)
- Xanthines (3)
- Alpha-2 Agonists (for ADHD) (0)
- Norepinephrine Reuptake Inhibitors (NRIs / ADHD) (0)
- Histamine H3 Antagonists / Inverse Agonists (0)
Opioids (36)
- Mu-Opioid Receptor Agonists (0)
- Natural opioids (4)
- Semisynthetic opioids (10)
- Synthetic opioids (16)
- Partial Mu-Opioid Agonists (0)
- Mixed Agonist-Antagonists (0)
- Κ-Opioid Receptor Agonists (0)
- Opioid Antagonists (3)
- Opioid Receptor Modulator + NMDA Antagonists (0)
- Opioid agonist therapy (0)
GABAergics (11)
- GABAB Receptor Agonists (0)
- GABAA Positive Allosteric Modulators (General) (0)
- GABA Reuptake Inhibitors (0)
- GABA-Transaminase Inhibitors (0)
- GHB Receptor Agonists (0)
- Sodium channel blockers (0)
- Calcium channel blockers (T-type or N/P/Q-type) (0)
- GABA enhancers (0)
- Glutamate/AMPA antagonists (0)
- SV2A ligands (0)
- Carbonic anhydrase inhibitors (0)
- Dopamine Precursors (0)
- Dopamine Agonists (0)
- MAO-B Inhibitors (0)
- COMT Inhibitors (0)
- Anticholinergics (Antiparkinsonian) (0)
- NMDA Antagonists (Antiparkinsonian) (0)
- Acetylcholinesterase Inhibitors (AChEIs) (0)
- NMDA Receptor Antagonists (0)
- Anti-Amyloid Monoclonal Antibodies (0)
Anesthetics (17)
- General (IV) Anesthetics (0)
- Inhalational Anesthetics (0)
- Dissociative Anesthetics (0)
- Local Anesthetics (5)
- Alpha-2 Agonist Sedatives (0)
Antihistamines (8)
- Opioid agonist therapy (0)
- Opioid Antagonists (3)
- Aversion agents (0)
- NMDA/GABA modulators for alcohol (0)
- Nicotinic partial agonists (0)
- Alpha-2 agonists for withdrawal (0)
Migraine Medicines (13)
- Triptans (5-HT1B/1D Agonists) (7)
- Gepants (CGRP Receptor Antagonists) (4)
- Ditans (5-HT1F Agonists) (0)
- Ergotamines (2)
Psychedelics (34)
- Classical Psychedelics (Serotonergic) (10)
- Tryptamines (24)
- Lysergamides (11)
- Phenethylamines (19)
- 2C-x series (0)
- DOx series (0)
- NBOMe / NBOH series (7)
- Empathogens / Entactogens (10)
- MDxx (0)
- Benzofurans (0)
- Dissociatives (15)
- Arylcyclohexylamines (10)
- Morphinans (0)
- Diarylethylamines (0)
- Adamantanes (0)
- Deliriants (9)
- Anticholinergics (anti-muscarinic) (0)
- Kainate / AMPA agonists (0)
- GABAA agonists (at sedating doses) (0)
- Κ-Opioid Receptor Agonists (0)
Cannabinoids (17)
Nootropics (9)
Research Materials (118)
- Lysergamides (11)
- Tryptamines (24)
- Phenethylamines (19)
- 2C-x series (0)
- DOx series (0)
- NBOMe / NBOH series (7)
- Cathinones (17)
- Pyrrolidinophenones (17)
- Novel Amphetamines (12)
- Novel Phenidates (8)
- Novel Dissociatives (Arylcyclohexylamines) (10)
- Novel / Designer Benzodiazepines (28)
- Beta-Carbolines (0)